Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
New restrictions to fight the Covid-19 pandemic are coming into force in many parts of France.
Read More
Cafe and restaurants owners in the Alpes Maritimes are to meet with the prefect today ahead of the possible closure of their establishments at 10pm du...
Read More
Two suspects are in custody after an attack near the former offices of Charlie Hebdo in Paris this morning. ...
Read More
Six new positive cases for Covid-19 have been reported in Monaco on Thursday. To date the total number of residents affected by the coronavirus stands...
Read More
